Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

  • Filter By:
  • Molecular Testing as the Basis for Targeted Therapies in NSCLC
  • CME
  • Molecular Testing as the Basis for Targeted Therapies in NSCLC

  • March 17, 2014
  • NSCLC comprises approximately 85% of all lung cancer cases. NSCLC histologies are primarily adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Certain genetic alterations have allowed… More »
  • Credit Type(s): CME | Credit: 1
  • Improve communication with iNHL patients
  • Top 10 Questions in Indolent B-cell non-Hodgkin Lymphoma

  • February 5, 2014
  • Learn about what hematologists/oncologists should be asking their patients with indolent B-cell non-Hodgkin lymphoma (iNHL) that has progressed during or within six months of treatment with rituximab… More »
  • MPN Updates

  • January 8, 2014
  • As the standards of care for patients with myeloproliferative neoplasms (MPNs) continue to evolve, physicians must stay informed on current research and treatment methods. MPN Updates, a… More »
  • CME
  • PD-1 Antibodies

  • July 22, 2013
  • This activity will review data on the efficacy, safety, and response patterns observed with PD-1 in patients with advanced melanoma… More »
  • Credit Type(s): CME | Credit: 0.25
  • CME
  • Building on the Success of CTLA-4 Blockade in Melanoma Immunotherapy

  • July 5, 2013
  • This activity will review data on the efficacy, safety, and response patterns observed with ipilimumab in patients with advanced melanoma… More »
  • Credit Type(s): CME | Credit: 0.25
  • CME
  • IL-2 Single Agent and Combinations

  • July 5, 2013
  • This activity will discuss the treatment of patients with melanoma via interleukin-2 as a single agent treatment as well as in combination with other therapies – such as ipilimumab, radiation… More »
  • Credit Type(s): CME | Credit: 0.25
  • CME
  • Management of Metastatic Melanoma 2013

  • June 10, 2013
  • After years of limited progress, significant advancements are being made regarding novel therapies for metastatic melanoma. This monograph will review emerging data that was presented during the 2013… More »
  • Credit Type(s): CME | Credit: 1.5